Presentation Information

[PE-093]Histologic and Combined Histologic and Endoscopic Outcomes After Guselkumab Maintenance Therapy in Chinese Patients With Moderately to Severely Active Ulcerative Colitis: Subgroup Analysis of the Phase 3 QUASAR Maintenance Study

Baili Chen1, Qian Cao2, *Yufang Wang3, Xuan Guo4, Shadi Yarandi5, Jiajia Lu6, Ye Miao5, Han GAO4, Minhu Chen1 (1. The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China, 2. Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China, 3. West China Hospital of Sichuan University, Chengdu, China, 4. Johnson & Johnson, Beijing, China, 5. Johnson & Johnson, Spring House, PA, USA, 6. Johnson & Johnson, Shanghai, China.)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Comment

To browse or post comments, you must log in.Log in